Herein we report on a large-scale analysis of gene expression in the 'learned helplessness' (LH) rat model of human depression, using DNA microarrays. We compared gene expression in the frontal cortex (FC) and hippocampus (HPC) of untreated controls, and LH rats treated with saline (LH-S), imipramine or fluoxetine. A total of 34 and 48 transcripts were differentially expressed in the FC and HPC, respectively, between control and LH-S groups. Unexpectedly, only genes for NADH dehydrogenase and zinc transporter were altered in both the FC and HPC, suggesting limited overlap in the molecular processes from specific areas of the brain. Principal component analysis revealed that sets of upregulated metabolic enzyme genes in the FC and downregulated genes for signal transduction in the HPC can distinguish clearly between depressed and control animals, as well as explain the responsiveness to antidepressants. This comprehensive data could help to unravel the complex genetic predispositions involved in human depression.
INTRODUCTION
Depression is a complex psychiatric disease with specific symptoms that include depressed mood, loss of interest, diminished appetite, sleep disturbances and psychomotor retardation. Depression is common, with lifetime prevalence estimated to be up to 20%, 1 and the condition exacts high personal and social costs on sufferers. The illness is also a major cause of suicide. Epidemiological studies suggest a genetic component to affective disorder, 1,2 and efforts to identify susceptibility genes by linkage and other genetic analyses are being conducted. 3 However, the precise etiologies remain elusive, as does the development of new therapies against depression, particularly for cases that are refractory to conventional therapy. In the case of complex trait diseases, isolating genetic mechanisms using human disease material is often difficult because of sample heterogeneity and other confounding factors. Analysis of suitable animal models under strictly controlled conditions would therefore be beneficial.
To investigate the molecular basis of depression, we have applied DNA microarray technology to analyze gene expressions in learned helplessness (LH) rats, an animal model of depression. After pretreatment with repeated inescapable shocks, animals with LH display decreased ability to escape adverse situations. This behavioral model was originally described in dogs, 4 and later analogous behavior was induced in rats. 5 LH animals display behavioral phenotypes resembling human depressive symptoms, and LH can be ameliorated using antidepressant drugs. 6, 7 LH therefore fulfills the parameters of construct validity, face validity and predictive validity, 8 confirming the suitability of the model for studying the neurobiology of depressive illness and the actions of antidepressants. [9] [10] [11] It is also important to note that the 'depressive state' in LH animals lasts for over 3 weeks, 12 making this model particularly useful for studying the chronic changes in brain physiology that accompany depression. We examined the frontal cortex (FC) and hippocampus (HPC) of LH rats, because positron emission tomography scanning and functional magnetic resonance imaging studies have recently indicated a potential abnormality in the frontal cortex of both familial bipolar and unipolar depressives. 13 In addition, recent evidence has suggested that neurogenesis in the HPC may be disturbed in depressive patients. [14] [15] [16] In this study, we have analyzed brain transcripts altered during LH and followed their responsiveness to a classical tricyclic antidepressant (TCA), imipramine, and a new generation selective serotonin reuptake inhibitor (SSRI), fluoxetine. In addition, we performed principal component analysis (PCA) to extract essential gene sets from complex expression data sets that can best explain the different pathophysiological conditions. This was achieved by considering genes as variables in PCA. When genes are variables, the analysis creates a set of principal gene components indicating the features of genes that best explain the experimental responses. Using these comprehensive pharmaco-behavioral genetic approaches, we have attempted to generate data that would eventually allow for the formulation of hypotheses to help understand the molecular and genetic pathophysiology of depression. This in turn could lead to the development of novel antidepressants with greater efficacy.
RESULTS AND DISCUSSION

Effectiveness of Antidepressants in Learned Helplessness
The LH model is difficult to generate, requiring meticulous refinement of multiple experimental parameters. In our experimental setting, after inescapable shock pretreatment, animals were subjected to 15 avoidance trials at 30 s intervals. In each trial, a current was applied via the floor grid during the first 3 s. If an animal moved to a neighboring compartment within this period (escape response), the shock was terminated. Failures in escape response were counted as a measure of LH. We defined animals as being in a state of LH when escape failures were demonstrated in more than half of the trials in the session. Using this system, we reproducibly induced LH in rats with a success rate of B40%. LH rats were subsequently treated with repeated injections of saline (LH-S), fluoxetine (LH-F) or imipramine (LH-I), then re-evaluated for escape responses in the test session. Figure 1 shows a schematic of these procedures. During the escapable shock of the test session, all animals in the LH-S group (n ¼ 10) showed more than eight escape failures, and the mean failure was significantly higher than that of control rats (those that were not given inescapable shock, n ¼ 15) (Figure 2 ). Antidepressant administration significantly reduced the number of escape failures for both LH-F (Po0.05) and LH-I (Po0.01). Imipramine recovered all To induce the LH state, animals were given inescapable shock (n) on day 1. On day 2, they received escapable shock (m), and were selected as 'LH rats' if they showed greater than 50% failure in escape responses. LH animals were then administered saline (LH-S) or antidepressants (LH-F, LH-I) for 4 consecutive days. These animals received escapable shock (m) again on day 5 to determine whether they were still in the LH state. (b) Control rats were not given inescapable shock on day 1, but treated in the same way thereafter as the LH rats. Figure 2 Mean number of escape failures (7SE) during the 15 avoidance trials. Controls (n ¼ 15) were not given inescapable shocks. Rats exposed to prior inescapable shocks were treated with saline (LH-S) (n ¼ 10), fluoxetine (LH-F) (n ¼ 7) or imipramine (LH-I) (n ¼ 9) once a day for consecutive days (days 2-5). Escape failure refers to the failure of animals to move into the safe compartment during electric footshock (0.5 mA, 3 s duration rats from the LH state (n ¼ 9), and fluoxetine reinstated five out of seven. These results confirm the persistency of LH in our animals and the effectiveness of antidepressants in this model. 5, [17] [18] [19] [20] Fluoxetine produced a weaker response compared to imipramine in alleviating the LH phenotype ( Figure  2 ). We also tested larger doses of each drug, 10 mg/kg i.p. of fluoxetine and 50 mg/kg i.p. of imipramine, but did not observe any significant change in the number of escape failures (10 mg/kg of fluoxetine, 5.071.0 (n ¼ 3); 50 mg/kg of imipramine, 2.071.3 (n ¼ 3)) between the two doses. In addition, Anthony et al 21 showed that 5 mg/kg of fluoxetine, the same dose as used in the present study, was enough to elicit monoaminergic perturbation such as a reduced 5-hydroxytryptamine receptor 1B expression in the dorsal raphe of rats. Bristow et al 22 also demonstrated the validity and efficacy of 5 mg/kg of fluoxetine in ameliorating depressive behavior in rats. We attempted to minimize the nonspecific effects of the drugs by using the lowest possible dose that maintained antidepressive efficacy.
LH-S
The present results may reflect the different clinical potencies of the individual agents. TCAs such as imipramine inhibit the reuptake of both serotonin and norepinephrine at nerve terminals by acting on monoamine transporters. In contrast, SSRIs including fluoxetine specifically block the reuptake of serotonin. 2 These differences in pharmacological profiles underlie the distinct antidepressive competences exerted by TCA and SSRI. Although human patients require over 2 weeks of medication before antidepressive effects are observed, we administered the drugs for 4 days in our rodent experiments, in keeping with the protocols of Geoffroy et al We also measured weight gain during the 5 days of experiments. Weight increase in the LH-S group was significantly lower than that in controls (LH-S, 18.874.4 g; control, 31.772.2 g; Po0.05).
General Profiles of Gene Expressions Associated with LH and Antidepressant Treatments
We selected six animals each from the control (rats showing no escape failure in the escapable shock session) and LH-S groups, and five each from the LH-F and LH-I groups (these showed p7 failures in the 15 trials), to perform microarray analyses. Patterns of gene expression in the two brain regions from the four rat groups were examined using the Affymetrix GeneChip U34A, which represents 8799 probe sets and codes over 8000 transcripts including known genes (45000) and expressed sequence tags (ESTs). Transcript expression from extracted RNA displayed good linearity in both FC and HPC samples ( Figure 3 ). Our stringent criteria identified 34 and 48 transcripts as differentially expressed between control (n ¼ 6) and LH-S (n ¼ 6) groups in the FC and HPC, respectively (henceforth referred to as 'LHassociated transcripts') ( Figures 3a and b) . However, none of these transcripts survived after the Benjamin and Hochbery False Discovery Rate analysis. This observation may confirm the statements of Mirnics et al 24 that true geneexpression changes in psychiatric traits are small and psychiatric diseases may result from cumulative subtle changes.
Among LH-associated transcripts, five transcripts and one gene showed significant recovery to control levels from the LH state under both imipramine (n ¼ 5) and fluoxetine (n ¼ 5) administration in the FC and HPC, respectively (white portions in Figures 4a and b) . Transcripts in the pink and yellow areas of Figure 4 represented expression levels that returned to normal after administration of imipramine and fluoxetine, respectively. Interestingly, no LH-associated transcripts demonstrated significant deviation from control levels after drug treatment. That is, none of the LHassociated genes were further decreased or excessively Figure 3 Scatter plot of log-intensity values for the over 8000 genes assayed with the RG-U34A chip in the frontal cortex (a) and hippocampus (b). Each point represents the log value from an average of six control or six LH-S animals.
increased after initiating therapy. Approximately 38% of LHassociated transcripts in the FC and 56% in the HPC could not be normalized by either antidepressant (Figure 4 ; red area). These transcripts could represent the potential targets for novel antidepressants with efficacy against refractory depression. The green, purple and light blue segments in Figure 4 depict the transcripts with expression levels that did not differ between control and LH-S groups, but were significantly altered by fluoxetine, imipramine or both drug treatments, respectively. The information on these transcripts is provided as supplementary Tables S1 and S2. Some of these transcripts may be relevant to the manifestation of adverse reactions by TCA and SSRI. Tables 1 and 2 show the listing of LH-associated transcripts according to putative functions, along with P-values between different treatment groups. Data are also provided on the 'average difference'7SE of each transcript (that corresponds to an absolute value) in supplementary Tables S1 and S2. In all, 17 known genes and one EST showed downregulation (marked in red), whereas 16 transcripts including ESTs were upregulated in the FC (Table 1 ). In contrast, the majority of known LHassociated genes in the HPC were downregulated (27 of 31) (marked in red in Table 2 ). Even allowing for ESTs, the number of downregulated transcripts in the HPC significantly exceeds the upregulated transcripts (32 vs 16) ( Table 2) .
We chose four genes from each of Tables 1 and 2 , and examined mRNA levels in the same RNA samples used for microarray experiments under 'one-step' quantitative RT-PCR reactions (Table 3) . These results showed the same direction of expressional changes seen in the microarray experiments, but less correlation was found with the degree of change between the two methods, as indicated in prior studies. 25, 26 Furthermore, since only a limited number of transcripts were confirmed by independent methods and no transcripts were confirmed when Bonferroni's correction was applied to the quantitative RT-PCR results, the present DNA microarray data are broadly unconfirmed.
LH-associated Transcripts in the FC
When classified according to function, genes defined as receptors or ion channel/transporters were all downregulated in LH animals ( Table 1) . Among them, the serotonin receptor type 2A (Htr2a) gene showed a 1.6-fold decrease, and recovery with both fluoxetine and imipramine. Evidence from other animal models for depression 27, 28 and clinical observations 29 have also suggested a pathological role for HTR2A in the depressive state. The change in inositol-1,4,5-triphosphate receptor type 1 (Itpr1) level was small, but statistically significant. Both types of antidepressant normalized the reduced expression of Itpr1. The observed decrease in both Htr2a and Itpr1 and their restitution to original levels by antidepressants is in keeping with a proposed theory of dysregulated monoaminemediated calcium signaling in depression. 30, 31 Other members of the receptor and ion channel/transporter gene families that showed restoration with fluoxetine or imipramine included a voltage-gated potassium channel and zinc transporter (Table 1) . Conversely, three genes from the signal transduction family were all upregulated in LH-S rats compared to controls (Table 1) . Of interest is prostaglandin D synthase, an enzyme that produces prostaglandin D 2 , a potent endogenous sleep-promoting substance. 32 This enzyme has recently been implicated in the regulation of nonrapid eye movement (NREM). 33 Sleep disturbance is a typical symptom of human depression. Examination of sleep parameters in LH rats, particularly the NREM period, would therefore be of interest. Protein kinase C epsilon (PKCe), which is a member of nPKC, showed a small but significant increase in LH-S compared with controls. Figure 4 Venn-diagram selection of LH-and antidepressant-associated transcripts in the frontal cortex (a) and hippocampus (b).
Control vs LH-S Control vs LH-S LH-S vs LH-F LH-S vs LH-F LH-S vs LH-I LH-S vs LH-I
Comparisons were made between control (n ¼ 6) and LH-S rats (n ¼ 6), between LH-S and LH-F rats (n ¼ 5), and between LH-S and LH-I rats (n ¼ 5). The LH-I and LH-F rats were those that showed more than 50% success in escape behavior after drug treatments. The number in each compartment denotes the number of differentially expressed transcripts between two groups (see Materials and Methods for a definition of our criteria).
Activation of serotonin 2 receptors reportedly diminished gamino butyric acid type A receptor current through PKC in prefrontal cortical neurons. 34 Expression changes in the Htr2a and PKCe genes in LH may indicate a functional link between the two systems in the depressive state. The precise role of neurexophilin 4 in the intercellular signaling system remains unclear, 35, 36 but the gene may underlie a depression/stress-related physiological pathway that cannot be corrected using TCAs or SSRIs (Table 1) . Of the LH-associated genes identified from the FC, LIMK-1 (LIM domain kinase 1: Limk1) displayed the most dramatic decrease, a 9.5-fold reduction compared with control levels (Table 1) . Transcriptional levels were not completely normalized by imipramine or fluoxetine treatment. This partial recovery might be due to the low level of normal transcription and the large variation of expression values (supplementary Table S3 ). We therefore performed real-time RT-PCR to confirm the expression profile of Limk1, and detected a two-fold decrease in LH compared to control animals. This reduction was not recovered by antidepressant treatments (Table 3) . Limk1 is expressed in both fetal and adult nervous systems, and shows ubiquitous expression in the brain with the strongest expression in adult cerebral cortex. 37 Recently, Limk1-knockout mice were reported to show abnormalities in spine morphology and enhanced long-term potentiation, accompanied by alterations in fear response and spatial learning. 38 A test of depression-related behavioral parameters in these mice would be intriguing. Additional reports that depressive patients frequently manifest subcortical hyperintensity near frontal white matter ('myelin pallor' on histological examination) 39 suggest that LIMK1 may be involved in an as yet undetermined intercellular signaling pathway disrupted in depression, as LIMK1 is known to phosphorylate myelin basic proteins. 40 Our criteria for selecting 'altered' transcripts in LH compared to control animals may have been conservative and inadvertently excluded many potential candidates. Decreased levels of brain-derived neurotrophic factor (BDNF) recoverable by antidepressant treatment have been reported in patients with depression.
41,42 Although we could not detect any significant difference in expression between control and LH-S animals, we found that expression of BDNF in the FC was increased in LH-I animals compared with LH-S and control animals (supplementary Table S3 ).
LH-associated Transcripts Specific to the HPC and Common to Both the FC and HPC
In contrast to the FC, most LH-associated genes in the HPC showed decreased expressions on the induction of LH (Table  2) . Genes coding for receptors were downregulated in both regions, although there was no overlap between the two groups of receptors. This category included three olfactory receptor-like genes, HGL-SL1 olfactory pseudogene, olfactory receptor-like protein (SCRD-9) and HFV-FD1 olfactory receptor. Although these are thought to encode G proteincoupled receptors with seven transmembrane domains, the biological functions are unclear. Heparin-binding fibroblast growth factor receptor 2 (Fgfr2) genes were also downregulated in LH-S, but were unaffected by antidepressants ( Table 2) . We also found a reduction in the N-methyl-Daspartate receptor 2A (NMDAR 2A) subunit gene in three of six LH-S animals. Fgfr2 reduces NMDAR 2A subunit mRNA levels via a receptor-mediated mechanism. 43 Chronic administration of antidepressants decreases the expression of NMDA receptor subunit genes and radioligand binding to the receptor. 42 This discrepancy warrants further investigation, to determine the role of this growth factor and the NMDA receptor genes in depression. All the LH-associated genes defined as involved in neurotransmission were also downregulated in this study ( Table 2 ). The hippocampus is well known as a region of the brain that is highly susceptible to stress. 44, 45 Recent studies have demonstrated that repeated stress causes shortening and debranching of dendrites in the CA3 region of the HPC and suppresses neurogenesis of granule neurons in the dentate gyrus. 45, 46 In addition, chronic antidepressant treatment increases cell populations and neurogenesis in the rat hippocampus. 15 The extensive suppression of gene expression observed in our LH model may be related to phenotypic changes in the hippocampus produced by stress.
An unexpected finding was the scarcity of common transcripts between the two areas of brain. Of the LHassociated genes, only those coding for the 24-kDa mitochondrial NADH dehydrogenase and Dri27/ZnT4 (zinc transporter) were common to both the FC and HPC (Tables  1 and 2 ). However, the direction of change differed between the two regions. This selectivity was also seen in genes that were not affected by LH, but displayed a response to 
Po0.05 (LH-S vs LH-I) by Mann-Whitney test (two-tailed).
Gene expression in learned helplessness rats N Nakatani et al treatment with fluoxetine, imipramine or both. In this case, from the three subsets (green, light blue and purple areas in Figure 4 ), five of 105 transcripts were common to both the FC and HPC (supplementary Tables S3 and S4 ). These findings may highlight region-specific molecular mechanisms involved in the etiology of LH. In human studies, decreased mitochondrial function was demonstrated in the basal ganglia of chronic schizophrenics, 47, 48 and inhibition of mitochondrial respiratory complex I activity was reported as a cellular pathology of Parkinson's disease. 49, 50 Evidence, including that of decreased ATP in frontal lobes detected in depressive patients, 51 has generated speculation about the role of mitochondrial dysfunction in depression. 52, 53 NADH dehydrogenase is located on human chromosome 18 at p11.31-p11.2, a susceptibility region for affective disorder and schizophrenia. 3, 54, 55 These data suggest a possible link between mitochondrial NADH dehydrogenase and neuropsychiatric illnesses, including depression. The observed alteration in levels of a zinc transporter gene may tie in with recent reports that zinc exerts an antidepressant-like effect in the rodent forced swimming test, 56 and that patients with major depression demonstrate lower serum zinc levels. 57 This may imply perturbed zinc metabolism in depression, but the precise mechanisms are poorly understood.
Given that imipramine was more effective in improving LH behavior than fluoxetine, it may seem contradictory that a larger number of LH-associated transcripts showed a greater response to fluoxetine than to imipramine ( Figure  4 ). Imipramine-responsive transcripts are likely to play a more pivotal role in behavioral recovery.
We also applied parametric statistical analysis (Student's ttest) to our array data. The total number of transcripts detected was slightly lower in both the FC and HPC compared to numbers detected by nonparametric tests (3 and 12 fewer in the FC and HPC, respectively). Between the two statistical methods, 10 genes in the FC (32%) and three genes in the HPC (8%) were different (supplementary Tables  S7 and S8) .
PCA on Altered Transcripts
PCA is a mathematical technique that exploits essential factors to define patterns in data, reducing the effective dimensionality of gene-expression space without significant loss of information.
58. This technique can be applied to both genes and experiments as a means of classification. When genes are variables, the analysis creates a set of principal gene components highlighting features of genes that best explain their experimental responses. We used the LHassociated transcripts from the FC and HPC separately as variables in PCA, to allow for better visualization of the region-specific data sets. Figures 5a and b indicate the eigenvalue distributions on the components in the FC and HPC samples, respectively. The sudden drop in eigenvalues with increasing component number suggests that it is possible to select a small number of components modeling the gene-expression differences among rat groups. We chose a three-component model for both the FC and HPC, which explained 56% of the total variability seen in the 34 transcripts from the FC and the 48 transcripts from the HPC. The extracted dimensions represent the linear organization of data from independent systems. Each animal was plotted in a three-dimensional subspace (Figures 6a and b) . The first components retain the maximal amount of correlated information (ie coordinated activity of genes) restricting the uncorrelated information to higher order components. In the FC, the first component (axis) showed good separation for the four experimental groups (control, LH-S, LH-F and LH-I), placing the antidepressant-treated groups between the control and LH-S groups. Table 4 shows Gene expression in learned helplessness rats N Nakatani et al transcripts from the FC that were arranged according to the magnitude of correlation with the first component (PC1) (those to the second and third components are shown in supplementary Table S5 ). They comprised genes for metabolic enzymes and stress responses. All genes listed in PC1 were increased in LH animals compared to controls. Among the genes coding for metabolic enzymes, the F1-ATPase epsilon subunit and 24-kDa subunit of mitochondrial NADH dehydrogenase are both localized to the mitochondria, further suggesting an important role for mitochondrial function in depression. 53 The second and third components in the FC did not further subdivide the experimental groups (supplementary figure S1). However, based on the data including the second component of PCA in the FC (supplementary Table S5 ), we speculate that genes responsible for neuronal growth and structure including Limk1 could be key factors in depression/stress-related pathology. In downstream pathways, alterations of these genes may affect recruitment and maintenance of multiple neurotransmitter receptors. 38 In support of this theory, structural abnormalities have recently been reported in the frontal lobe white matter of depressive patients. 59 According to PC1 in the HPC, LH-S rats were separated from controls, with the drug-treated animals being more closely localized than the LH-S group (Figure 6b) . This highlights the limited efficacy of TCA and SSRI antidepressants against dysregulated genes in the HPC, although these drugs reversed the behavioral phenotype of LH rats. The genes contributing to PC1 from the HPC would therefore represent suitable targets for future novel antidepressants. PC1 in the HPC contained genes that were downregulated in LH rats and were clustered as metabolic enzyme and signal transduction ( Table 4 ). The second component in the HPC detected eight genes that correlated with responsiveness to fluoxetine (supplementary Table S6 and Figure S2 ). One animal was separated from the others along the third component (Figure 6b ). The reason for this was not clear. The animal may have suffered from highly aberrant expression of metabolic enzyme-and signal transductionrelated genes and other transcripts (Table 4) . Finally, the fact that the 24-kDa subunit of mitochondrial NADH dehydrogenase was extracted from both the FC and HPC with high eigenvalues is intriguing, suggesting that this gene may represent an indicator of depressive state. Moreover, the two genes, for soluble cytochrome b5 on 18q23 and Rab3 on 1p32-p31, mapped to reported linkage regions for bipolar disorder. 60 
MATERIALS AND METHODS
Animals and Experimental Design
Male Sprague-Dawley rats, 5-6-week old, weighing 150-180 g, were purchased from SLC (Shizuoka, Japan). They were housed three per cage under standard laboratory conditions, with access to food and water ad libitum. After 1 week of handling, the animals were used for experiments. Antidepressants, imipramine and fluoxetine were purchased from SIGMA (St Louis, MO, USA).
On day 1, animals were subjected to IS pretreatment (0.5 mA, 10 s duration, shock interval 1-5 s, 160 trials) in a Plexiglas chamber (460 W Â 200 D Â 180 H mm 3 , Muromachi, Tokyo, Japan). Two rats were processed simultaneously using two chambers. Control rats were placed for 1 h in the same chambers, but no shocks were administered.
On day 2, to evaluate escape and avoidance performance, avoidance training was initiated 24 h after IS pretreatment in the same chamber, which had been converted to a twoway shuttle box by dividing it into two equal-sized compartments using an aluminum partition. The partition included a square gate (6 Â 6 cm 2 ), through which animals Figure 6 All animals were plotted with respect to the first (blue), second (green) and third (red) principal components. PCA was performed on transcripts listed in Table 1 (frontal cortex) (a) and Table 2 (hippocampus) (b). Yellow-colored dots represent control animals, green LH-S rats, red LH-F and blue LH-I.
could move into the adjacent compartment. Animals were subjected to 15 avoidance trials with 30 s intervals. In each trial, 0.5 mA of current was applied via the grid floor during the first 3 s. If an animal crossed the gate and moved to the other compartment within this period (escape response), the shock was terminated. Failures in escape response were counted as a measure of LH. Animals were defined as suffering from LH when they showed eight or more failures during a session. Control rats and a proportion of LH rats (LH-S) were administered saline once a day for three consecutive days, starting on day 2 after the avoidance trial. The remaining LH animals were treated using either imipramine (25 mg/kg, i.p.) (LH-I) or fluoxetine (5 mg/kg, i.p.) (LH-F). On day 5, 30 min after the final injection, rats were tested for escape ability under escapable shock conditions. Among LH-I and LH-F rats, only those animals that showed a 450% successful escape response (ie o8 failures in the 15 trials; all LH-I rats fulfilled this criterion) were used for geneexpression analysis.
The present protocol was approved by the RIKEN animal committee.
RNA Preparation and Array Hybridization
Animals were killed on day 6, 24 h after the final electroshock procedure. Total RNA was extracted from the FC (defined as the region anterior to the genu of corpus callosum, with the ventral olfactory structures depleted) and HPC using an acid guanidium thiocyanate/phenol chloroform extraction method (ISOGEN, NIPPON Gene, Toyama, Japan). Double-stranded cDNA was synthesized from 10 mg of total RNA using the SuperScript Choice System (Invitrogen, Carlsbad, CA, USA) and a primer containing poly (dT) and a T7 RNA polymerase promoter sequences (Geneset, La Jolla, CA, USA). Biotin-labeled cRNA was synthesized from cDNA using an Enzo BioArray High Yield RNA Transcript Labeling kit (Enzo Diagnostics, Santa Clara, CA, USA). After fragmentation, 15 mg of cRNA was hybridized for 16 h at 451C to a U34A chip (Affymetrix, Santa Clara, CA, USA) that contained probes for over 8000 transcripts, including all known rat genes (http://www.affymetrix.com/products/netaffx.html). After hybridization, arrays were washed automatically and stained with streptavidin-phycoerythrin using the fluidics system. Chips were scanned using a GeneArray scanner (Affymetrix).
Data Analysis
All samples were scaled to a target intensity of 100. Data analysis was performed using Microarray Suite 4.0 (Affymetrix) and GeneSpring 4.1 (Silicon Genetics, Redwood, CA, USA). Transcripts with an 'average difference' (as described in the GeneChip software) of o20 for each probe set in controls were excluded (5157 genes were selected out of 8799). From the remaining transcripts, those that gave an 'absolute call' of 'P' (present) for at least four samples in six for control and LH-S rats were considered for further analysis (3541 genes were chosen).
Before statistical analysis, each transcript was converted into a logarithmic value and normalized to itself by making a synthetic positive control and dividing all measurements by this control, assuming that the control value was at least 0.01. A synthetic control is the median of the transcript's expression values over all the samples. Two-group comparison was conducted for each transcript by a Mann-Whitney test between: (i) control and LH-S groups, (ii) LH-S and LH-F groups and (iii) LH-S and LH-I groups. The results are illustrated as a Venn diagram (Figure 2) , where the overlapping areas representing (i)-, (ii)-and (iii)-type comparisons include transcripts that were selected solely using Mann-Whitney test (Po0.05) and Student's t-test (Po0.05). Transcripts in non-overlapping areas represent genes whose expressional changes between the two states displayed X1.4-fold difference, in addition to fulfilling the P-value criteria. We also evaluated these selected transcripts by implementing the Benjamin and Hochbery False Discovery Rate program included in the GeneSpring software package. The differential gene expressions revealed by the microarray chips were examined using real-time quantitative reverse transcription (RT)-PCR, with a LightCycler and RNA Amplification kit SYBR Green I (Roche, Basel, Swizerland).
Principal Component Analysis
PCA is a statistical method for determining the coordinate transformation that explains the maximum amount of variance for the data. 25 . PCA finds the principal components and each component is mutually orthogonal. To calculate the transformation, data were first normalized with reference to each gene, and then sample mean and sample variance-covariance matrix S were calculated from estimates of the mean and variance-covariance matrix. From this symmetrical matrix S, an orthogonal basis was calculated by determining eigenvalues and eigenvectors according to the equation:
where E is an identity matrix and l i is the ith eigenvalue. i takes the value (1 to n), and n is the total number of genes.
where A i is the ith eigenvector (n-dimension). The first and ith principal components were calculated as follows:
where A 1 is the eigenvector with maximum eigenvalue, and D is the n-dimensional data vector. The proportion of the ith component was the ith eigenvalue divided by the total sum of all eigenvalues. Animals were projected into the first three-dimensional component space.
62,63
CONCLUSION
In an effort to better understand the molecular and genetic bases underlying the pathophysiology of depressive disorder and to improve the rationale for the design of antidepressant drugs, we have performed DNA microarray analysis using an animal model of depression. Using Affymetrix GeneChip arrays, we have screened over 8000 rat genes and ESTs, and identified 82 distinct transcripts (Tables 1 and 2,  and supplementary Tables S1 and S2) in the FC and HPC that are relevant to LH and responsive to conventional antidepressants. To date, the strategy for designing antidepressive drugs is based on the serendipitous paradigm that the augmentation of monoaminergic activity in the central nervous system leads to therapeutic benefits. 1 However, currently available drugs have several drawbacks in terms of slow onset of action and intractable disease presents in approximately one-third of all depressive patients. 61 Given the genetically complex nature of human depression, we recognize that the present study can explain only limited aspects of depression pathology. Nevertheless, we believe that this study could give rise to new ideas for probing into the genetic mechanisms of human affective disorder and for refining the development of advanced therapeutics.
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